Global Vision Holdings Inc. (OTCQB), Announced Today the Naming of Their New CEO, George England Jr.

IRVINE, CA / ACCESSWIRE / January 31, 2024 / Global Vision Holdings Inc. (OTCQB), announces the naming of their new CEO, George England Jr. For the last 4 years, Mr. England has served as CEO and founder of 909 Healthcare, Inc. Mr. England has 30 plus …

IRVINE, CA / ACCESSWIRE / January 31, 2024 / Global Vision Holdings Inc. (OTCQB), announces the naming of their new CEO, George England Jr. For the last 4 years, Mr. England has served as CEO and founder of 909 Healthcare, Inc. Mr. England has 30 plus years of experience as a successful healthcare entrepreneur and executive. He has consulted with national start-up companies in the healthcare vertical with a focus on healthcare IT, clinical outcome data and ancillary services.

"My passion is creating collaborative digital health solutions by utilizing the latest technology including AI, Data Analysis, and Health Risk Predictive Modeling." explained George England. "Identifying and resolving disruptive patterns in healthcare services and delivery has proven to bring significant increases in financial and clinical outcomes" he continued. "I look forward to bringing these proven technology solutions to Global Vision Holdings, Inc," Mr. England concluded.

About Global Vision Holdings, Inc.

About 909 Healthcare, Inc.

Healthcare is a technology company that develops SaaS applications. Their expertise is to identify and resolve undesirable medical conditions by utilizing AI driven, collaborative digital health and wellness experiences that promote connection, collaboration and mitigate risk.

Their stated mission is to eliminate the overwhelming complexity, waste and unsustainable costs that are prevalent in the delivery of healthcare. The 909 Healthcare digital technology solution has proven to produce better financial and clinical outcomes.

visit: https://909healthcare.com/
visit: https://medtechdx.com/

Disclaimer

Some of the statements in this press release may be forward-looking statements or statements of future expectations based on currently available information. Such statements are naturally subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. 909 Healthcare and George Mason University does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such statements. Therefore, in no case whatsoever will 909 Healthcare and George Mason University and its affiliate companies be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages.

SOURCE: Global Vision Holdings, Inc.

View the original press release on accesswire.com

Total
0
Shares
Previous Article

Disney UNCF Corporate Scholars Named for 2024 Cohort

Next Article

oakpool Makes Alex Delano a Partner

Related Posts

Taconic Biosciences® Launches Cage+™, Redefining Colony Management Solutions for the Modern Laboratory

Stewardship Approach Safeguards All Elements of Contract Breeding Services RENSSELAER, N.Y., Feb. 21, 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, launched Cage+, a holistic, innovative approach to murine contract breeding services. Cage+ delivers complete stewardship of projects from start to finish, allowing investigators to focus on […]

TTCF NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Tattooed Chef, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TTCF

NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tattooed Chef, Inc. (NASDAQ: TTCF) between March 20, 2021 and October 12, 2022, both dates inclusive (the “Class Period”), of the important February 21, 2023 lead plaintiff deadline in the securities class […]

Sustainalytics Upgrades INNIO Group’s ESG Risk Rating From Low to Negligible Risk, Ranking INNIO Number 1 Worldwide Among Industry Peers

Sustainalytics ESG rating places INNIO in top 1 percentile of all industry peers and in top 2 percentile of companies rated by Sustainalytics on a global level. • INNIO receives Sustainalytics’ ESG risk score of 9.8, improving by 11% compared to 2022. • INNIO also receives Sustainalytics’ 2023 “ESG Industry Top rated” and “ESG Regional […]